Pharmacological Targeting of Adenosine-to-Inosine (A-to-I) RNA Editing in Aggressive Breast Cancer Subtypes

腺苷至肌苷 (A-to-I) RNA 编辑在侵袭性乳腺癌亚型中的药理学靶向

• 批准号: 469587
• 负责人: Ali Suhad
• 金额: $ 75.51万
• 依托单位: Research Institute of the McGill University Health Centre
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-09-01 至 2027-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469587&lang=en
• 关键词: Pharmacological Studies

Breast cancer is a complex disease having a major impact on society across the world. In particular, patients diagnosed with certain types of aggressive breast cancer subtypes not only have limited therapies but also a prospect of early recurrence of the

乳腺癌是一种复杂的疾病，对世界各地的社会产生重大影响。特别地，被诊断患有某些类型的侵袭性乳腺癌亚型的患者不仅具有有限的疗法，而且具有早期复发的前景。